FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2751556360> ?p ?o ?g. }

• W2751556360 abstract "Constipation and symptoms of gastrointestinal discomfort such as bloating are common among otherwise healthy individuals, but with significant impact on quality of life. Despite the recognized contribution of the gut microbiome to this pathology, little is known about which group(s) of microorganism(s) are playing a role. A previous study performed in vitro suggests that EpiCor® fermentate has prebiotic-like properties, being able to favorably modulate the composition of the gut microbiome. Therefore, the aim of this study was to investigate the effects of EpiCor fermentate in a population with symptoms of gastrointestinal discomfort and reduced bowel movements and to evaluate its effect at the level of the gut microbiome. This pilot study was performed according to a randomized, double-blind, placebo-controlled parallel design. Eighty subjects with symptoms of gastrointestinal discomfort and constipation were allocated to one of two trial arms (placebo or EpiCor fermentate). Randomization was done in a stratified manner according to symptom severity, resulting in two subgroups of patients: severe and moderate. Daily records of gastrointestinal symptoms were assessed on a 5-point scale, and also stool frequency and consistency were documented during a 2-week run-in and a 6-week intervention phases. Averages over two-week intervals were calculated. Constipation-associated quality of life and general perceived stress were assessed at baseline and after 3 and 6 weeks of intervention. Fecal samples were also collected at these same time points. EpiCor fermentate led to a significant improvement of symptoms such as bloating/distension (p = 0.033 and p = 0.024 after 2 and 4 weeks of intervention, respectively), feeling of fullness (p = 0.004 and p = 0.023 after 2 and 4 weeks of intervention, respectively) and general daily scores (p = 0.046 after 2 weeks of intervention) in the moderate subgroup. A significant improvement in stool consistency was observed for the total population (p = 0.023 after 2 weeks of intervention) as well as for the severe subgroup (p = 0.046 after 2 weeks of intervention), and a nearly significant increase in stool frequency was detected for the total cohort (p = 0.083 and p = 0.090 after 2 and 4 weeks of intervention, respectively). These effects were accompanied by an improvement in constipation-associated quality of life and general perceived stress, particularly in the moderate subgroup. Members of the families Bacteroidaceae and Prevotellaceae, two groups of bacteria that have been previously reported to be deficient in constipated patients, were found to increase with EpiCor fermentate in the severe subgroup. In the moderate subgroup, a significant increase in Akkermansia muciniphila was observed. Despite the relatively low dose administered (500 mg/day), particularly when comparing to the high recommended doses for prebiotic fibers, EpiCor fermentate was able to modulate the composition of the gut microbiome, resulting in improvement of constipation-associated symptoms. Conversely, the reported increase in bowel movements may have altered the gut microbial community by increasing those groups of bacteria that are better adapted to a faster gastrointestinal transit time. NCT03051399 at ClinicalTrials.gov. Retrospectively registered. Registration date: 13 February 2017." @default.
• W2751556360 created "2017-09-15" @default.
• W2751556360 creator A5007994796 @default.
• W2751556360 creator A5026615089 @default.
• W2751556360 creator A5060074811 @default.
• W2751556360 creator A5067774235 @default.
• W2751556360 creator A5069123203 @default.
• W2751556360 creator A5090769189 @default.
• W2751556360 creator A5091833658 @default.
• W2751556360 date "2017-09-04" @default.
• W2751556360 modified "2023-09-26" @default.
• W2751556360 title "A yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome: results from a randomized double-blind placebo-controlled pilot trial" @default.
• W2751556360 cites W114039365 @default.
• W2751556360 cites W143697486 @default.
• W2751556360 cites W1527498429 @default.
• W2751556360 cites W1612577459 @default.
• W2751556360 cites W1632356912 @default.
• W2751556360 cites W1793035576 @default.
• W2751556360 cites W1963821027 @default.
• W2751556360 cites W1965814102 @default.
• W2751556360 cites W1966250447 @default.
• W2751556360 cites W1968105193 @default.
• W2751556360 cites W1971562218 @default.
• W2751556360 cites W1973659539 @default.
• W2751556360 cites W1977829433 @default.
• W2751556360 cites W1979267894 @default.
• W2751556360 cites W1993434123 @default.
• W2751556360 cites W1996299251 @default.
• W2751556360 cites W2004923528 @default.
• W2751556360 cites W2010523539 @default.
• W2751556360 cites W2012800693 @default.
• W2751556360 cites W2019419945 @default.
• W2751556360 cites W2027490473 @default.
• W2751556360 cites W2030970409 @default.
• W2751556360 cites W2040646645 @default.
• W2751556360 cites W2043599476 @default.
• W2751556360 cites W2045276152 @default.
• W2751556360 cites W2046549547 @default.
• W2751556360 cites W2047677813 @default.
• W2751556360 cites W2053176597 @default.
• W2751556360 cites W2058834052 @default.
• W2751556360 cites W2065994042 @default.
• W2751556360 cites W2067762602 @default.
• W2751556360 cites W2069500838 @default.
• W2751556360 cites W2071886628 @default.
• W2751556360 cites W2073837934 @default.
• W2751556360 cites W2075157391 @default.
• W2751556360 cites W2078272272 @default.
• W2751556360 cites W2079281535 @default.
• W2751556360 cites W2087292184 @default.
• W2751556360 cites W2091922579 @default.
• W2751556360 cites W2092466285 @default.
• W2751556360 cites W2096947655 @default.
• W2751556360 cites W2106017790 @default.
• W2751556360 cites W2114295370 @default.
• W2751556360 cites W2116725404 @default.
• W2751556360 cites W2118669156 @default.
• W2751556360 cites W2123812491 @default.
• W2751556360 cites W2124310253 @default.
• W2751556360 cites W2124351063 @default.
• W2751556360 cites W2142293392 @default.
• W2751556360 cites W2146199929 @default.
• W2751556360 cites W2147790901 @default.
• W2751556360 cites W2147997235 @default.
• W2751556360 cites W2148638310 @default.
• W2751556360 cites W2151159165 @default.
• W2751556360 cites W2152885278 @default.
• W2751556360 cites W2156286274 @default.
• W2751556360 cites W2164719160 @default.
• W2751556360 cites W2474248819 @default.
• W2751556360 cites W2529713053 @default.
• W2751556360 cites W2536273036 @default.
• W2751556360 cites W2548795875 @default.
• W2751556360 cites W4211008591 @default.
• W2751556360 cites W4230635053 @default.
• W2751556360 cites W4240875076 @default.
• W2751556360 cites W4247290531 @default.
• W2751556360 cites W45534775 @default.
• W2751556360 doi "https://doi.org/10.1186/s12906-017-1948-0" @default.
• W2751556360 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5584023" @default.
• W2751556360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28870194" @default.
• W2751556360 hasPublicationYear "2017" @default.
• W2751556360 type Work @default.
• W2751556360 sameAs 2751556360 @default.
• W2751556360 citedByCount "22" @default.
• W2751556360 countsByYear W27515563602018 @default.
• W2751556360 countsByYear W27515563602019 @default.
• W2751556360 countsByYear W27515563602020 @default.
• W2751556360 countsByYear W27515563602021 @default.
• W2751556360 countsByYear W27515563602022 @default.
• W2751556360 countsByYear W27515563602023 @default.
• W2751556360 crossrefType "journal-article" @default.
• W2751556360 hasAuthorship W2751556360A5007994796 @default.
• W2751556360 hasAuthorship W2751556360A5026615089 @default.
• W2751556360 hasAuthorship W2751556360A5060074811 @default.
• W2751556360 hasAuthorship W2751556360A5067774235 @default.
• W2751556360 hasAuthorship W2751556360A5069123203 @default.
• W2751556360 hasAuthorship W2751556360A5090769189 @default.
• W2751556360 hasAuthorship W2751556360A5091833658 @default.
• W2751556360 hasBestOaLocation W27515563601 @default.

• next